A study conducted using the Florida Cancer Data System revealed that the causes of hepatocellular carcinoma (HCC) vary significantly based…
Browsing: Clinical Updates
Of several potential advances in the treatment of gastrointestinal cancers presented at the 2023 annual meeting of the American Society…
A recent study published in the Annals of Internal Medicine revealed a significant communication gap regarding colorectal cancer (CRC) screening.…
Ulcerative colitis (UC) is a chronic inflammatory condition affecting the colon. In North America, its prevalence surpasses 400 per 100,000…
In June 2023, a multisociety group agreed to change the name of the disease formerly known as nonalcoholic fatty liver…
In this edition of “Sharma’s Endoscopy Insights,” I highlight two studies related to resection—an approach to ulcerative colitis–related lesions and…
NEW YORK, Sept. 7, 2023 /PRNewswire/ — Lucid Diagnostics Inc. (Nasdaq: LUCD) (“Lucid” or the “Company”) a commercial-stage, cancer prevention medical diagnostics company, and majority-owned subsidiary…
A recent clinical trial has indicated that using resistant starch as a microbiota-directed dietary supplement could be a promising intervention…
The article delves into the potential of fecal microbiota transplantation (FMT) as a treatment for ulcerative colitis (UC). A comprehensive…
A comprehensive review and meta-analysis of 25 studies, involving approximately 30,000 adults, revealed that behavioral interventions can significantly enhance colonoscopy…